Overview

Intra-arterial Microplasmin Administration in Patients With Acute Peripheral Arterial Occlusion

Status:
Terminated
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of the trial is to evaluate the safety and efficacy of microplasmin administration in patients with acute peripheral arterial occlusion.
Phase:
Phase 2
Details
Lead Sponsor:
ThromboGenics
Treatments:
Fibrinolysin
Plasminogen